Introduction {#s1}
============

The origin of homochirality in biological macromolecules has been a subject of active research and intense debate till date ([@bib34]; [@bib5]). With the selection of only L-amino acids (L-aas) for incorporation in proteins, effective enforcement and perpetuation of homochirality became essential for an efficient translational machinery to be a part of living systems. To this end, multiple checkpoints ensure that only L-aas are incorporated during translation. These include aminoacyl-tRNA synthetases (aaRSs), elongation factor Tu (EF-Tu) and ribosome ([@bib21]; [@bib33]; [@bib4]; [@bib44]; [@bib2]; [@bib1]; [@bib31]). Many aaRSs possess proofreading modules that remove similar non-cognate L-aas mistakenly attached to tRNAs and thus ensure fidelity of translation ([@bib30]; [@bib37]; [@bib11]). However, a freestanding enzyme D-aminoacyl-tRNA deacylase (DTD) removes D-amino acids (D-aas) mischarged on tRNAs and ensures that D-aas do not get incorporated into proteins ([@bib9]; [@bib43]; [@bib45]). Since DTDs act in *trans* as freestanding modules, they are most likely to operate through resampling by recapturing aminoacyl-tRNAs (aa-tRNAs) from EF-Tu ([@bib28]).

A DTD-like fold has been found appended to archaeal threonyl-tRNA synthetase (ThrRS) where it removes mischarged L-serine from tRNA^Thr^ ([@bib12]; [@bib20], [@bib19]). The structure of archaeal ThrRS editing domain from *Pyrococcus abyssi* (Pab-NTD) not only highlighted the evolutionary link between DTD and Pab-NTD but also suggested the probable role this fold might have played in enforcement of homochirality during early evolution of translational machinery, since weakly discriminating primordial aaRSs would have been less enantioselective ([@bib12]). Even some of the highly evolved present day aaRSs have been shown to be inherently weak in enantioselection, leading to the formation of D-aminoacyl-tRNAs (D-aa-tRNAs) ([@bib8]; [@bib39]). D-aa-tRNAs thus formed could either get incorporated into the growing polypeptide chain leading to global misfolding or get accumulated in the cell leading to depletion of tRNA pool. Either way, decoupling of D-aa from tRNA is extremely important which makes the cellular role of DTD crucial.

DTD activity was originally identified in 1967 by Calendar and Berg and the function is conserved in all organisms including humans ([@bib9]; [@bib45]). So far three distinct types of DTDs have been reported. The most commonly found canonical DTD has been shown to be present in most bacteria and all eukaryotes ([@bib40]). Archaea, on the other hand, lack canonical DTD sequence in their genomes and instead possess another structurally unrelated protein which carries out the function of deacylating D-aa-tRNAs ([@bib15]). This functional equivalent of DTD has been termed DTD2 and it is found in archaea and plants ([@bib42]). The third type of DTD, known as DTD3, has been reported in some cyanobacteria that lack both canonical DTD and DTD2 ([@bib43]). Overall, the universal distribution of DTD function across the three domains of life clearly suggests an essential role DTDs must have played and continue to play in enforcing homochirality. From here on, DTD would refer to the canonical DTD found in bacteria and eukaryotes unless otherwise mentioned. The DTD sequence is highly conserved among prokaryotes and eukaryotes with the sequence identity between *Escherichia coli* and *Homo sapiens* being 39%. The biological significance of DTD has been shown in both prokaryotes and eukaryotes with deletion of *dtd* gene leading to reduced tolerance to several D-aas in a dose-dependent manner ([@bib38], [@bib39], [@bib41]; [@bib45]). DTD is ubiquitously expressed and shows high levels of expression in the human neuronal cells, which are abundant in D-aas, thus strongly indicating a critical role of DTD ([@bib45]).

Mechanistically, the most remarkable challenge that DTD faces is to specifically act on multiple D-aa-tRNAs while rejecting L-aminoacyl-tRNAs (L-aa-tRNAs) without any specificity for either the amino acid or the tRNA. This can be seen from the fact that DTD is able to act on diverse substrates such as Tyr, Phe, Asp, and Trp as long as they carry a D-configuration of the amino acid on tRNA ([@bib9]; [@bib39]). The problem is further compounded by the very high excess of L-aa-tRNA over D-aa-tRNA in the cellular milieu and warrants a stringent D-configuration specificity to avoid depletion of L-aa-tRNA pool. Although biochemical studies have indicated its configurational preference, the mechanistic basis of this fundamental process remained elusive due to lack of a cognate substrate-bound complex structure.

The first crystal structure of DTD from *E. coli* (*Ec*DTD) was solved in the apo form, which identified this novel DTD-like fold ([@bib16]). Later, the apo structures of DTD from *Haemophilus influenzae* ([@bib25]), *Aquifex aeolicus* (PDB id: [2DBO](http://www.rcsb.org/pdb/explore/explore.do?structureId=2DBO)) and *H. sapiens* ([@bib22]) also became available. In the absence of any ligand-bound structure, docking studies were done with *H. influenzae* DTD in an attempt to understand its mechanism ([@bib25]). Recently, the structure of *Plasmodium falciparum* DTD (*Pf*DTD) was solved in complex with ADP and multiple free D-aas ([@bib3]). Although these studies had proposed a catalytic mechanism implicating the role of a Thr residue, the structural basis of DTD's strict enantioselectivity was not clear. In this study, we report the mechanism of this crucial process with the help of high resolution structures of *Pf*DTD in complex with a substrate-mimicking analog. We further validate the mechanistic proposal with the help of biochemical assays conducted on *Pf*DTD as well as *Ec*DTD and NMR-based binding studies with *Pf*DTD. The work identifies the essential role of a universally conserved 'cross-subunit' Gly-*cis*Pro motif in providing exclusive enantioselectivity to the enzyme thus ensuring homochirality during translation.

Results {#s2}
=======

Co-crystal structure of *Pf*DTD with D-Tyr3AA {#s2-1}
---------------------------------------------

*Pf*DTD was co-crystallized with a post-transfer substrate analog D-Tyr3AA, which mimics D-tyrosine attached to the 3′-OH of the terminal adenosine (A76) of tRNA ([Figure 1](#fig1){ref-type="fig"}). The ester linkage between amino acid and adenosine is replaced by an amide linkage to make it non-hydrolyzable. Similar post-transfer substrate analogs have been used extensively to study proofreading mechanisms in atomic details for both Class I-specific CP1 editing domains and Class II-specific editing domains ([@bib26]; [@bib11]; [@bib17]; [@bib20], [@bib19]).The crystal structure of *Pf*DTD in complex with D-Tyr3AA has been solved in two different crystal forms: crystal form I at a resolution of 1.86 Å in C2 space group and crystal form II at a resolution of 2.2 Å in P2~1~ space group ([Table 1](#tbl1){ref-type="table"}). Crystal forms I and II have two and eight copies per asymmetric unit, respectively. This provides us with 10 independent observations of the ligand in the active site ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). Since all copies present a similar picture, the higher resolution crystal form I is discussed here unless otherwise mentioned ([Figure 2A](#fig2){ref-type="fig"}). The enzyme is a symmetric dimer with two active sites per dimer that are located at the dimeric interface ([Figure 2B,C](#fig2){ref-type="fig"}). The residues defining the active site pocket span the conserved --SQFTL-- motif from one monomer and the --NXGP(V/F)T-- motif from the other. The D-Tyr3AA-bound structure superimposes on the apo structure (PDB id: [3KNF](http://www.rcsb.org/pdb/explore/explore.do?structureId=3KNF)) with an r.m.s.d. of 0.41 Å for 260 Cα atoms ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}). However, there are subtle rearrangements of the active site region upon ligand binding, indicating the plasticity associated with the active site ([Figure 2D](#fig2){ref-type="fig"}). The most noticeable movements occur in Phe89, Phe137 and Gly138 upon accommodation of D-Tyr3AA making the active site more compatible for substrate binding ([Figure 2D](#fig2){ref-type="fig"}).10.7554/eLife.01519.003Figure 1.Comparison of the actual substrate with the analog used in this study.(![](elife01519inf001.jpg)) The 5′-OH is linked to tRNA in the actual substrate, whereas it is free in D-Tyr3AA. (![](elife01519inf002.jpg)) The ester bond in the real substrate is replaced by an amide bond in the analog D-Tyr3AA to make it non-hydrolyzable.**DOI:** [http://dx.doi.org/10.7554/eLife.01519.003](10.7554/eLife.01519.003)10.7554/eLife.01519.004Figure 1---figure supplement 1.Stereoscopic images showing the positions of earlier modeled ligands with respect to the cognate substrate-mimicking analog D-Tyr3AA in DTD.(**A**) Comparison of the docked substrate ([@bib25]) with D-Tyr3AA captured in the co-crystal structure. In their study, Lim et al. have docked the entire substrate that is D-Tyr-tRNA onto *Haemophilus influenzae* DTD but here only the terminal adenosine is shown for the sake of comparison. To prepare the figure, the ligand has been placed based on the stereoscopic image provided by [@bib25]. The docked substrate complex does not match with the D-Tyr3AA as found in the experimental structure presented here. (**B**) The position of ADP ([@bib3]) is actually completely outside the pocket when compared to D-Tyr3AA complex. (**C**) The positions and orientations of various D-amino acids captured ([@bib3]) with respect to the cognate substrate analog D-Tyr3AA. None of the D-amino acids is found to be located in the position where the chiral discrimination occurs (the distance between Cα of the D-amino acids and Cα of D-Tyr3AA ranges from 3.39 Å to 13.94 Å). The site of binding as well as the orientation of D-amino acids with respect to the enzyme is highly variable. In some cases, the carboxylate group points towards the enzyme, whereas in some cases it projects outward. Considering that in the actual substrate, the D-amino acid would be linked to the tRNA, a multiple binding mode is highly improbable as the orientation and position of the D-amino acid would be fixed by the binding of terminal adenosine.**DOI:** [http://dx.doi.org/10.7554/eLife.01519.004](10.7554/eLife.01519.004)10.7554/eLife.01519.005Figure 1---figure supplement 2.The reported structures of proofreading domains with substrate-mimicking analogs.The substrate analog-bound structures that represent the biologically relevant complexes of proofreading domains invariably occupy the deepest available pocket having a striking surface complementarity. This can be clearly seen in the well-studied cases of Class I-specific CP1 domains, Class II-specific editing domain of *E. coli* ThrRS and Pab-NTD. The D-Tyr3AA complex presented in this study also shows these features evidently. However, the ADP complex ([@bib3]) shows ADP clinging onto the surface, leaving the deepest pocket unoccupied. It may also be noted here that ADP is not a substrate for this enzyme.**DOI:** [http://dx.doi.org/10.7554/eLife.01519.005](10.7554/eLife.01519.005)10.7554/eLife.01519.006Table 1.Crystallographic data collection and refinement statistics**DOI:** [http://dx.doi.org/10.7554/eLife.01519.006](10.7554/eLife.01519.006)PfDTD+D-Tyr3AAPfDTD+D-Tyr3AACrystal ICrystal II(PDB id: [4NBI](http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4NBI))(PDB id: [4NBJ](http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4NBJ))Data Collection Space groupC2P2~1~ Cell dimensions: *a* (Å)82.1390.90 *b* (Å)65.7479.91 *c* (Å)56.9295.02 β (°)93.3093.51 Resolution range (Å)[\*](#tblfn1){ref-type="table-fn"}25.0--1.86 (1.93--1.86)25.0--2.20 (2.28--2.20) Total Observations178996449245 Unique reflections25156 (2283)69275 (6911) Completeness (%)98.3 (89.3)100 (99.9) R~merge~ (%)7.5 (28.3)11.8 (59.3) \<I/(σ)I\>29.4 (5.5)17.7 (2.8) Redundancy7.1 (6.4)6.5 (5.9)Data refinement Resolution (Å)1.862.20 No. of reflections2387865743 R (%)16.7719.46 R~free~ (%)[†](#tblfn2){ref-type="table-fn"}19.2525.35 Monomers/a.u.28 No. of residues3231289 No. of atoms291710727 Protein259510104 Ligand72248 Water250375 R.m.s. deviation Bond lengths (Å)0.0070.010 Bond angles (°)1.0931.436 Mean B value (Å^2^)30.3348.11 Protein29.0947.69 Ligand43.9453.30 Water41.2957.16[^2][^3]10.7554/eLife.01519.007Figure 2.Structure of DTD in complex with D-Tyr3AA.(**A**) A (2Fo--Fc) map contoured at 1.2σ clearly showing unambiguous density for the ligand D-Tyr3AA from crystal form I solved at 1.86 Å resolution. (**B**) Dimeric DTD with the two monomers shown in green and cyan. The conserved--SQFTL--and--NXGP(V/F)T--motifs are depicted in violet and orange respectively. The ligand binds in the two active sites located at the dimer interface. The two tRNAs have been schematically represented. (**C**) Surface representation showing D-Tyr3AA in the pocket. Inset is a magnified image showing the side chain of D-tyrosine protruding out of the pocket. The ligand has been colored according to the B-factors. (**D**) Structural rearrangements in the substrate pocket upon D-Tyr3AA binding highlighting the plasticity of the active site. The apo is shown in green and the complex is shown in purple. The ligand has been made transparent for clarity. (**E**) Stereoscopic representation showing the interactions between the ligand and the active site residues (\* indicates residues from the other monomer).**DOI:** [http://dx.doi.org/10.7554/eLife.01519.007](10.7554/eLife.01519.007)10.7554/eLife.01519.008Figure 2---figure supplement 1.Electron density for the ligand in all observations.(2Fo--Fc) maps contoured at 1.2σ for all monomers from crystal forms I and II showing clear unambiguous densities for the ligand D-Tyr3AA.**DOI:** [http://dx.doi.org/10.7554/eLife.01519.008](10.7554/eLife.01519.008)10.7554/eLife.01519.009Figure 2---figure supplement 2.Superimposition of D-Tyr3AA-bound complex structure of *Pf*DTD (pink) on the apo structure (green).The complex structure overlaps with the apo structure with an r.m.s.d. of 0.41 Å over 260 Cα atoms.**DOI:** [http://dx.doi.org/10.7554/eLife.01519.009](10.7554/eLife.01519.009)10.7554/eLife.01519.010Figure 2---figure supplement 3.Superimposition of *Pf*DTD on Pab-NTD.*Pf*DTD has been shown in blue and Pab-NTD is depicted in pink. The two structures overlap with an r.m.s.d. of 1.65 Å over 118 Cα atoms.**DOI:** [http://dx.doi.org/10.7554/eLife.01519.010](10.7554/eLife.01519.010)10.7554/eLife.01519.011Figure 2---figure supplement 4.Comparison of ligand interaction in *Pf*DTD and Pab-NTD.The adenine is recognized by a conserved set of interactions in both *Pf*DTD and Pab-NTD, including an invariant Phe residue which stacks with the adenine base.**DOI:** [http://dx.doi.org/10.7554/eLife.01519.011](10.7554/eLife.01519.011)10.7554/eLife.01519.012Figure 2---figure supplement 5.Atomic B-factors plotted for all the ligand atoms from both crystal forms I and II.The atomic B-factor is given by the equation: B~i~ = 8π^2^U~i~^2^ (where U~i~ is the mean square displacement of atom i). It is a measure of atomic displacement. High B-factors indicate flexibility while ordered regions have low B-factors. A sharp rise in the B-factors can be observed in the amino acid moiety beyond the Cβ atom. Another peak is observed around the C5′ and 5′-OH of ribose since it is placed out of the pocket. A dip at the carbonyl oxygen of the amino acid highlights the strong recognition of this atom in the active site pocket.**DOI:** [http://dx.doi.org/10.7554/eLife.01519.012](10.7554/eLife.01519.012)10.7554/eLife.01519.013Figure 2---figure supplement 6.Superimposition of D-Tyr3AA from all monomers of crystal forms I and II.The adenine and ribose superimpose on top of each other very well. However, the amino acid moiety shows significant deviations. The maximum variation is observed beyond the Cβ atom of the substrate.**DOI:** [http://dx.doi.org/10.7554/eLife.01519.013](10.7554/eLife.01519.013)

Adenosine binding and catalytic mechanism {#s2-2}
-----------------------------------------

The active site of DTD uses, in a major way, the main chain atoms to interact with the substrate ([Figure 2E](#fig2){ref-type="fig"}). The main chain atoms of Lys107 and Ile43 have direct and water-mediated interactions with the adenine moiety. An invariant Phe137 provides base-stacking interaction to the adenine ring. The main chain nitrogen of Gly138 along with the side chain hydroxyl of Ser87 holds the 2′-OH. The 5′-OH projects outwards as should be expected since it would be attached to the preceding nucleotide (C75) in the actual substrate, which is D-aa-tRNA. Considering that Pab-NTD, which is a structural homolog of DTD ([Figure 2---figure supplement 3](#fig2s3){ref-type="fig"}), also interacts with the substrate mostly through main chain atoms, it appears to be a conserved feature of this fold to employ main chain atoms extensively for ligand binding ([Figure 2---figure supplement 4](#fig2s4){ref-type="fig"}) ([@bib20], [@bib19]). Moreover, the adenosine-binding pocket is highly conserved in this DTD-like fold with an invariant Phe providing base-stacking interaction (Phe117 in Pab-NTD and Phe137 in *Pf*DTD) as shown in [Figure 2---figure supplement 4](#fig2s4){ref-type="fig"}. To prove that the ligand complex we have obtained is a biologically relevant one, we disrupted the adenine-binding pocket with the help of mutations and showed that it leads to complete loss of activity. As shown in [Figure 3A](#fig3){ref-type="fig"}, Phe137 that stacks with the adenine base was mutated to Ala. In another mutant, we blocked the adenine pocket by mutating a conserved Ala112 to a bulkier Phe ([Figure 3A](#fig3){ref-type="fig"}). Both F137A and A112F mutations resulted in a complete loss of activity, confirming that the adenosine-binding pocket identified here indeed represents the bona fide functional site ([Figure 3B](#fig3){ref-type="fig"}). The corresponding mutations F125A and A102F in *Ec*DTD were also tested for their activity against D-Tyr-tRNA^Tyr^. These mutants in *Ec*DTD also showed a complete loss of activity ([Figure 3---figure supplement 1B](#fig3s1){ref-type="fig"}), further substantiating the biological relevance of the substrate-binding pocket identified here.10.7554/eLife.01519.014Figure 3.Mutational analysis of the active site residues.(**A**) Stereoscopic depiction showing mutations generated in the adenine-binding pocket: Stick representation is used for wild-type residues while mutants are depicted in spheres. Phe137 was mutated to Ala and Ala112 was mutated to Phe. (**B**) Deacylation of D-Tyr-tRNA^Tyr^ by buffer (![](elife01519inf003.jpg)), wild-type *Pf*DTD (![](elife01519inf004.jpg)), F137A (![](elife01519inf005.jpg)), A112F (![](elife01519inf006.jpg)), S87A (![](elife01519inf007.jpg)), S87P (![](elife01519inf008.jpg)), Q88A (![](elife01519inf009.jpg)) and T90A (![](elife01519inf010.jpg)). 500 pM enzyme concentration was used for the assays. (**C**) Stereoscopic image showing all the protein side chains within 6 Å of the susceptible bond of the substrate. A water molecule has been modeled based on Pab-NTD complex structure. The water is positioned at a distance of 2.61 Å from the 2′-OH and 2.79 Å from the scissile bond of D-Tyr3AA. In the absence of any protein side chain playing a role in catalysis, a substrate-assisted mechanism is proposed involving the role of 2′-OH of tRNA in activating a water molecule as suggested in case of Pab-NTD.**DOI:** [http://dx.doi.org/10.7554/eLife.01519.014](10.7554/eLife.01519.014)10.7554/eLife.01519.015Figure 3---figure supplement 1.Mutational analysis of the active site residues in *Pf*DTD and *Ec*DTD.(**A**) Deacylation of D-Tyr-tRNA^Tyr^ by buffer (![](elife01519inf003.jpg)), wild type *Pf*DTD (![](elife01519inf004.jpg)), Q88E (![](elife01519inf005.jpg)), Q88N (![](elife01519inf005.jpg)), T90S (![](elife01519inf007.jpg)). 500 pM enzyme concentration was used for all assays. (**B**) Deacylation of D-Tyr-tRNA^Tyr^ by buffer (![](elife01519inf003.jpg)), wild-type *Ec*DTD (![](elife01519inf004.jpg)), F125A (![](elife01519inf007.jpg)), A102F (![](elife01519inf008.jpg)), S77A (![](elife01519inf006.jpg)), S77P (![](elife01519inf005.jpg)), Q78A (![](elife01519inf010.jpg)), T80A (![](elife01519inf009.jpg)). 50 nM enzyme concentration was used for all assays.**DOI:** [http://dx.doi.org/10.7554/eLife.01519.015](10.7554/eLife.01519.015)10.7554/eLife.01519.016Figure 3---figure supplement 2.Mutational data on the earlier identified binding modes in DTD.(**A**) The ADP-bound structure as reported earlier shows only one conserved interaction where the adenine base stacks with Phe89 while the phosphate tail hangs out (PDB id: 3KO5). (**B**) Thr90 that was earlier proposed to be the catalytic residue has its γ-hydroxyl group oriented away from the point of attack and is tightly held by highly conserved interactions with Thr152 main chain atoms from the other monomer. (**C**) Deacylation of D-Tyr-tRNA^Tyr^ by buffer (![](elife01519inf007.jpg)), wild type *Pf*DTD (![](elife01519inf008.jpg)), F89A (![](elife01519inf005.jpg)) and T90A (![](elife01519inf006.jpg)). 500 pM of enzyme was used for each assay. Although T90A deacylation curve has been shown in [Figure 3B](#fig3){ref-type="fig"}, it is shown again here for immediate reference. (**D**) Deacylation of D-Tyr-tRNA^Tyr^ by buffer (![](elife01519inf007.jpg)), wild type *Ec*DTD (![](elife01519inf008.jpg)), F79A (![](elife01519inf005.jpg)) and T80A (![](elife01519inf006.jpg)). 50 nM of enzyme was used for each assay. Although T80A deacylation curve has been shown in [Figure 3---figure supplement 1B](#fig3s1){ref-type="fig"}, it is shown again here for immediate reference.**DOI:** [http://dx.doi.org/10.7554/eLife.01519.016](10.7554/eLife.01519.016)

To delineate the catalytic mechanism, we looked for all the amino acid side chains located within a distance of 6 Å from the susceptible bond of the substrate, that is the bond between adenosine and the carbonyl group of D-tyrosine. These residues include Ser87, Gln88, Phe89, Thr90, Met141, and Pro150. Out of these, the residues that can chemically contribute to catalysis are Ser87, Gln88, and Thr90, which are positioned at a distance of 5.71 Å, 3.56 Å, and 5.72 Å respectively from the carbonyl carbon of the substrate ([Figure 3C](#fig3){ref-type="fig"}).

To probe the role played by these residues in catalysis, we generated mutants S87A, S87P, Q88A, Q88N, Q88E, T90A, and T90S, and tested them for deacylation activity. All mutants deacylated D-Tyr-tRNA^Tyr^ as efficiently as the wild type *Pf*DTD, except S87A that showed partly compromised activity ([Figure 3B](#fig3){ref-type="fig"}, [Figure 3---figure supplement 1A](#fig3s1){ref-type="fig"}). Although S87A was only moderately active, the fact that S87P retains complete activity rules out any catalytic role for this residue. Therefore, even though Ser87 interacts with 2′-OH of the ribose, it seems to perform a space-filling function of maintaining the ribose in an active conformation. It is also worth noting here that in some DTDs from different organisms, Ser87 is naturally substituted by a Pro, which further proves that the side chain chemistry of this residue is not essential for catalysis. The catalytic role of other protein residues Gln88 and Thr90 can also be ruled out as Q88A, Q88N, Q88E, T90A, and T90S mutants deacylated D-Tyr-tRNA^Tyr^ as efficiently as the wild type ([Figure 3B](#fig3){ref-type="fig"}, [Figure 3---figure supplement 1A](#fig3s1){ref-type="fig"}). Strikingly, Thr90 was identified from the modeling studies ([@bib25]) as a crucial residue responsible for catalysis, as discussed further in a later section. However, mutating this residue did not at all affect the activity of the enzyme. The corresponding mutants S77A, S77P, Q78A, and T80A in *Ec*DTD were also tested for their deacylation activity. In the case of *Ec*DTD, all mutants including S77A deacylated D-Tyr-tRNA^Tyr^ as efficiently as the wild type ([Figure 3---figure supplement 1B](#fig3s1){ref-type="fig"}). The above data suggest that none of the protein residues around the scissile bond are involved in catalysis.

Our earlier structural studies on Pab-NTD have suggested an RNA-assisted catalytic mechanism implicating the role of 2′-OH in activating a water molecule for catalysis ([@bib20], [@bib19]). Subsequently, the catalytic role of RNA in proofreading has also been experimentally shown in the case of phenylalanyl-tRNA synthetase (PheRS) ([@bib27]). Unlike in the case of PheRS, the catalytic role of RNA in DTD could not be directly probed with a modified tRNA having a terminal 2′-deoxyadenosine since tyrosyl-tRNA synthetase (TyrRS) attaches the amino acid on 2′-OH of the ribose, which is then transesterified to 3′-OH for proofreading reaction. As we show later, this transesterification is required for DTD to act since it is expected to recognize aminoacyl moiety only when it is attached to the 3′-OH. A comparison of non-cognate and cognate substrate analog-bound structures of Pab-NTD had revealed that the space available in the reaction zone is crucial for catalysis. It was shown that upon cognate substrate binding this space is constricted due to a subtle movement of a crucial Lys side chain ([@bib19]). This limited space, therefore, does not allow the putative catalytic water molecule to be accommodated in that site as it would have serious short contacts, and hence no deacylation. Although we do not observe a water molecule in that region in DTD, there is enough space available for a water molecule to be positioned without any clashes. Furthermore, it is worth noting here that the site of catalysis in DTD is much more accessible to the external bulk solvent as compared to Pab-NTD and could be a plausible reason as to why we do not observe the water molecule crystallographically. Therefore, considering the structural similarity and conservation of substrate-binding modes between DTD and Pab-NTD along with the experimental evidence showing the absence of any direct role of protein side chains in the catalytic mechanism, we propose a similar RNA-assisted catalysis in DTD also ([Figure 3C](#fig3){ref-type="fig"}). The 2′-OH of the terminal ribose would activate a water molecule, which in turn makes a nucleophilic attack on the carbonyl carbon of the substrate. The resultant tetrahedral transition state would be stabilized by the oxyanion hole formed by main chain nitrogen atoms of Phe89 and Thr90 situated at a distance 3.03 Å and 4.05 Å respectively from the carbonyl oxygen of the substrate. It would then result in the subsequent cleavage of the ester bond between the D-aa and the tRNA. Therefore, taken together with studies on Pab-NTD and the primordial nature of its fold and function, the above data indicate that the DTD fold is an RNA-based catalyst in the proofreading reaction.

Enantioselection mechanism {#s2-3}
--------------------------

A striking feature of the amino acid recognition site is the capture of all the atoms attached to the chiral centre Cα and the role of cross-subunit interactions, particularly a Gly-*cis*Pro motif from both monomers inserted into the active site of the dimeric counterpart that plays a central role in the recognition mechanism, as described in 'Mechanism of L-amino acid rejection from the active site'. The aminoacyl moiety has interactions with residues from both monomers. The carbonyl oxygen interacts with the main chain nitrogen of Phe89 and the side chain amide of Gln88. Both the residues belong to the --SQFTL-- motif. The α-amino group of D-tyrosine has an interaction with carbonyl oxygen of Gly149 from the cross-subunit Gly-*cis*Pro motif. Such a capture of the carbonyl oxygen and the amino group of the incoming D-aa, automatically positions the Cβ in such a way that it makes favorable C-H^...^O hydrogen bond with the carbonyl oxygen of Pro150, again from the cross-subunit Gly-*cis*Pro motif. In addition, the Cα also makes a weak C-H^...^N bond with the Gln88 side chain amide nitrogen. The interaction distances of the aminoacyl moiety have been summarized in [Supplementary file 1A](#SD1-data){ref-type="supplementary-material"}. With this mode of recognition of the configuration, the side chain of D-tyrosine is positioned in such a way that it projects out of the binding pocket and has no interaction beyond the Cβ atom as seen in [Figure 2C](#fig2){ref-type="fig"}. The atomic B-factors of the ligand clearly show a sharp rise in the side chain atoms beyond the Cβ ([Figure 2C](#fig2){ref-type="fig"}, [Figure 2---figure supplement 5](#fig2s5){ref-type="fig"}, [Supplementary file 1B](#SD1-data){ref-type="supplementary-material"}). The superimposition of all the copies of ligand from both the crystal forms I and II shows considerable deviations in only the side chain atoms beyond Cβ ([Figure 2---figure supplement 6](#fig2s6){ref-type="fig"}). The lack of recognition of side chain atoms indicates that residues with different side chain chemistries and sizes are treated alike. Such a side chain-free recognition mechanism provides the basis for how nature has designed a single deacylase to deal with any D-aa-tRNA and reveals the crucial role played by weak hydrogen bonds in D-chirality selection.

Mechanism of L-amino acid rejection from the active site {#s2-4}
--------------------------------------------------------

If an L-aa was to bind in this pocket, it would have to do so in one of the three theoretically possible conformations shown in [Figure 4](#fig4){ref-type="fig"}. In conformation I, where the side chain swaps positions with Hα, it would result in serious clashes with several atoms in the binding pocket ([Figure 4C](#fig4){ref-type="fig"}). Even the Cβ of L-Tyr would have short contacts of 3.08 Å with the Cδ and 2.69 Å with the carbonyl oxygen of Pro150. In conformation II, the side chain would occupy the place of the amino group ([Figure 4D](#fig4){ref-type="fig"}). In this position it would be placed adjacent to 5′-OH and would therefore have short contacts with the preceding nucleotide (C75). In fact, the Cβ itself would have a short contact (2.56 Å) with the amide nitrogen of the substrate (ester oxygen in the real substrate). It should be highlighted here that the side chain rejection in both positions occurs at the Cβ level itself, which implies that an amino acid with even a minimal side chain like L-Ala will be rejected from occupying these two positions. In the third possibility of conformation III, the amino group would swap its position with Hα ([Figure 4E](#fig4){ref-type="fig"}). In this case, in addition to losing its hydrogen bonding interaction with Gly149 carbonyl oxygen, the amino group would be placed also in an unfavorable environment at a distance of 3.07 Å from the Cδ atom of the non-polar side chain of Pro150 ([Figure 4E](#fig4){ref-type="fig"}). This provides an elegant mechanistic design for L-chirality rejection from this pocket irrespective of the conformation and side chain chemistry of the incoming substrate. The rejection mechanism also rules out any other possible mode of D-aa binding than the one observed where the side chain is kept protruding out ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}).10.7554/eLife.01519.017Figure 4.Mechanism of L-chirality rejection.The cross-subunit Gly-*cis*Pro motif is shown in brown. (**A**) Stereoscopic representation showing the conformation of D-amino acid observed in the pocket. (**B**) The adenosine moiety and the carbonyl oxygen are tightly fixed. The only allowed flexibility would be the torsion around Cα-C′ bond. This rotation gives rise to three theoretical possibilities of binding an L-amino acid. (**C**) Conformation I: the side chain swaps positions with Hα, severe short contacts of the side chain atoms including Cβ with active site residues can be seen. (**D**) Conformation II: the side chain swaps positions with NH~2~ group, short contact of side chain with C75 of tRNA, also Cβ is 2.56 Å from amide nitrogen (N8) of the substrate. (**E**) Conformation III: the NH~2~ group swaps positions with Hα, non-polar side chain of Pro150 provides unfavorable environment for NH~2~ group.**DOI:** [http://dx.doi.org/10.7554/eLife.01519.017](10.7554/eLife.01519.017)10.7554/eLife.01519.018Figure 4---figure supplement 1.Theoretically possible modes of D-amino acid binding.The cross-subunit Gly-*cis*Pro motif is shown in brown. (**A**) The conformation of D-amino acid observed in the pocket; all the groups on the chiral Cα are captured. (**B**) Possibility 2: side chain occupies the position of Hα, severe short contacts of the side chain atoms including Cβ with active site residues can be seen. (**C**) Possibility 3: side chain occupies the position of NH~2~, the side chain would have short contacts with C75 of tRNA, Cβ would have short contacts with N8 and polar NH~2~ would be close to the non-polar Pro150 side chain.**DOI:** [http://dx.doi.org/10.7554/eLife.01519.018](10.7554/eLife.01519.018)

The 'cross-subunit' Gly-*cis*Pro motif plays a central role in the rejection of L-aas from binding in the pocket. The *cis* conformation of Pro150 is the key to ensuring that it cradles the chiral centre thus preventing both the amino group and the Cβ from occupying the position of Hα ([Figure 5A](#fig5){ref-type="fig"}). To facilitate this rejection mechanism, Pro150 side chain is positioned rigidly in *cis* conformation by a conserved hydrophobic base formed by Phe40, Val86, Ile143, and the DTD-specific invariant Met141 ([Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}). The Gly149 and Pro150 carbonyl oxygens make H-bond interactions with the α-amino group and the Cβ of the substrate respectively, thereby reinforcing the binding of D-aa in the pocket. Both the carbonyl oxygens are also positioned tightly by cross-subunit interactions with Met141 main chain nitrogen and Gln88 side chain nitrogen, respectively ([Figure 5A](#fig5){ref-type="fig"}). The structure, therefore, suggests a strict rejection of L-aas from the pocket, enabling DTD to specifically remove only D-aas coupled to tRNAs.10.7554/eLife.01519.019Figure 5.Strict configurational specificity of DTD.(**A**) The Gly-*cis*Pro motif from one monomer protrudes into the active site of the other monomer and cradles the chiral center of the substrate and provides basis for configuration selection. The carbonyl oxygens are tightly positioned by cross-subunit interactions. (**B**) Deacylation of L-Tyr-tRNA^Tyr^ by buffer (![](elife01519inf007.jpg)), 500 pM (![](elife01519inf005.jpg)), 5 nM (![](elife01519inf006.jpg)), 50 nM (![](elife01519inf003.jpg)), 500 nM (![](elife01519inf004.jpg)) *Pf*DTD and D-Tyr-tRNA^Tyr^ deacylation by 500 pM *Pf*DTD (![](elife01519inf008.jpg)). (**C**) L-Tyr-tRNA^Tyr^ deacylation by buffer (![](elife01519inf007.jpg)), 50 nM (![](elife01519inf005.jpg)), 500 nM (![](elife01519inf006.jpg)), 5 μM (![](elife01519inf003.jpg)) *Ec*DTD and D-Tyr-tRNA^Tyr^ deacylation by 50 nM *Ec*DTD (![](elife01519inf008.jpg)). (**D**) Excerpts of overlay of 2D ^15^N-^1^H TROSY obtained with 0.2 mM *Pf*DTD (black) and upon addition of 1 mM (red), 2 mM (blue), 3 mM (green) D-Tyr3AA and L-Tyr3AA.**DOI:** [http://dx.doi.org/10.7554/eLife.01519.019](10.7554/eLife.01519.019)10.7554/eLife.01519.020Figure 5---figure supplement 1.Hydrophobic base for Pro150 side chain.The Pro150 side chain is supported by a hydrophobic base comprising of Phe40, Val86, Met141, and Ile143 side chains from the other monomer.**DOI:** [http://dx.doi.org/10.7554/eLife.01519.020](10.7554/eLife.01519.020)10.7554/eLife.01519.021Figure 5---figure supplement 2.2D ^15^N-^1^H TROSY of *Pf*DTD with D-Tyr3AA and L-Tyr3AA.Overlay of 2D 15N-^1^H TROSY obtained with 0.2 mM*Pf*DTD (black) and upon addition of 1 mM (red), 2 mM (blue), 3 mM (green) D-Tyr3AA and L-Tyr3AA.**DOI:** [http://dx.doi.org/10.7554/eLife.01519.021](10.7554/eLife.01519.021)10.7554/eLife.01519.022Figure 5---figure supplement 3.TLC-based deacylation assay with *Pf*DTD wild type against D-Tyr-tRNA^Tyr^ and L-Tyr-tRNA^Tyr^.The resultant aminoacyl-AMP and AMP from S1 nuclease digestion, run as distinct spots on TLC.**DOI:** [http://dx.doi.org/10.7554/eLife.01519.022](10.7554/eLife.01519.022)

Conservation of the strict configuration specificity across species {#s2-5}
-------------------------------------------------------------------

In order to prove the strict rejection of L-aa by the active site of DTD, biochemical analyses with *Pf*DTD were performed. Although significant deacylation activity against D-Tyr-tRNA^Tyr^ was observed at 500 pM *Pf*DTD, no L-Tyr-tRNA^Tyr^ deacylation was found even with 1000-fold higher enzyme concentration at 500 nM ([Figure 5B](#fig5){ref-type="fig"}). Furthermore, to rule out the possibility of any *Plasmodium*-specific phenomenon and to test the universal nature of the rejection mechanism, we carried out deacylation experiments with *Ec*DTD as well. Similar to *Pf*DTD, *Ec*DTD showed significant deacylation of D-Tyr-tRNA^Tyr^ with 50 nM enzyme, whereas no detectable L-Tyr-tRNA^Tyr^ deacylation was seen even at 5 μM ([Figure 5C](#fig5){ref-type="fig"}). Biochemical studies with both enzymes not only confirm the stringent chiral specificity of this key process but also suggest conservation of the mechanism across species.

Strict rejection of L-aa-tRNA as seen with NMR-based binding studies {#s2-6}
--------------------------------------------------------------------

We further probed the enantiomeric rejection mechanism in solution using NMR-based 2D ^15^N-^1^H Transverse Relaxation Optimized Spectroscopy (TROSY) experiments with a nonhydrolyzable analog mimicking L-Tyr attached to tRNA^Tyr^, L-Tyr3AA, and compared it with D-Tyr3AA. Titration of ^15^N-*Pf*DTD with D-Tyr3AA at molar ratios of 1:0, 1:5, 1:10, and 1:15 led to chemical shift perturbations in a number of resonances and showed saturation around 1:15, thereby clearly indicating a specific binding to *Pf*DTD ([Figure 5D](#fig5){ref-type="fig"}, [Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}). On the other hand, L-Tyr3AA titration did not cause any change in the amide resonances of ^15^N-*Pf*DTD even up to 1:15 molar ratio, highlighting a complete lack of specific binding ([Figure 5D](#fig5){ref-type="fig"}, [Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}). Thus, the 2D ^15^N-^1^H TROSY studies further confirmed the strict rejection of L-aa from the active site of DTD.

2′-vs 3′- deacylase {#s2-7}
-------------------

Another important mechanistic aspect that is clearly evident from this structure is that DTD acts exclusively on D-aas charged on 3′-OH of the terminal adenosine. aaRSs aminoacylate tRNAs at either 2′-OH or 3′-OH in a class-dependent way ([@bib14]). Biochemical studies have revealed deacylation mechanism of DTD against aa--tRNA pairs belonging to both classes of aaRS. However, it was not clear whether DTDs would act on D-aas linked to 2′-OH or 3′-OH or both. The structure shows that the 2′-OH is positioned in a confined area with the help of tight interactions with Gly138 main chain nitrogen and Ser87 side chain hydroxyl group. Modeling even the simplest of amino acids on the 2′-OH shows severe steric clashes irrespective of the ribose pucker ([Figure 6A--C](#fig6){ref-type="fig"}). We have further confirmed this mechanistic proposal using 2D ^15^N-^1^H TROSY experiments. Titration of ^15^N-*Pf*DTD with D-Tyr3AA showed chemical shift perturbations for a number of resonances ([Figure 5D](#fig5){ref-type="fig"}, [Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}). On the other hand, titration with D-Tyr2AA (analog of D-tyrosine bound to 2′-OH of adenosine) resulted in no observable chemical shift perturbations ([Figure 6D,E](#fig6){ref-type="fig"}). This confirms that the enzyme acts on tRNAs only when the amino acid is either attached to 3′-OH or transferred to 3′-OH from 2′-OH through rapid transesterification. A similar mechanistic mode of operation of Pab-NTD delineates this DTD-like fold as a 3′-specific deacylase enzyme ([@bib20], [@bib19]).10.7554/eLife.01519.023Figure 6.DTD is a strict 3'-specific deacylase.(**A**) Ribose moiety of D-Tyr3AA adopts C3′-endo pucker in the structure. Modeling the aminoacyl group on the 2′-OH shows serious steric clashes in (**B**) C3′-endo as well as (**C**) C2′-endo puckers. (**D**) Overlay of 2D ^15^N-^1^H TROSY obtained with 0.2 mM *Pf*DTD (black) and upon addition of 1 mM (red), 2 mM (blue), 3 mM (green) D-Tyr2AA. (**E**) Excerpt of the overlay for clarity.**DOI:** [http://dx.doi.org/10.7554/eLife.01519.023](10.7554/eLife.01519.023)

Gly-*cis*Pro motif is essential for function {#s2-8}
--------------------------------------------

The mechanistic understanding based on the cognate substrate analog-bound structure suggests a crucial role for the cross-subunit Gly-*cis*Pro motif in enantioselectivity and rejection of L-aas from the pocket. To experimentally demonstrate the crucial role of this unique motif for DTD function, we carried out deacylation assays with *Pf*DTD by mutating these two critical residues. A complete loss of activity was observed for both G149A and P150A mutants ([Figure 7A](#fig7){ref-type="fig"}). We also carried out deacylation assay with G149A/P150A double mutant and similar to both single mutants, it showed a total loss of activity ([Figure 7A](#fig7){ref-type="fig"}). The biochemical studies, thus clearly, show that Gly-*cis*Pro motif is essential for DTD function. We further wanted to ensure that the observation is not *Plasmodium*-specific. Therefore, we performed the same biochemical study with the mutants of *Ec*DTD to ensure that the critical role of the Gly-*cis*Pro motif is universal. Similar to *Pf*DTD, both G137A and P138A mutants of *Ec*DTD showed a complete loss of deacylation function ([Figure 7B](#fig7){ref-type="fig"}). We also tested G137A/P138A double mutant for deacylation function and it also showed no activity like the individual point mutants ([Figure 7B](#fig7){ref-type="fig"}). The biochemical analyses with the mutants of both *Pf*DTD and *Ec*DTD prove the critical role played by the unique Gly-*cis*Pro motif in DTD function and also suggests the universality of its crucial role irrespective of the organism.10.7554/eLife.01519.024Figure 7.Critical role of Gly-*cis*Pro motif for DTD function.(**A**) Deacylation of D-Tyr-tRNA^Tyr^ by buffer (![](elife01519inf007.jpg)), *Pf*DTD wild type (![](elife01519inf008.jpg)), G149A (![](elife01519inf005.jpg)), P150A (![](elife01519inf006.jpg)) and G149A/P150A double mutant (![](elife01519inf003.jpg)). 500 pM enzyme concentration was used for all reactions. (**B**) D-Tyr-tRNA^Tyr^ deacylation by buffer (![](elife01519inf007.jpg)), *Ec*DTD wild type (![](elife01519inf008.jpg)), G137A (![](elife01519inf005.jpg)), P138A (![](elife01519inf006.jpg)), and G137A/P138A double mutant (![](elife01519inf003.jpg)). 50 nM enzyme concentration was used for all reactions.**DOI:** [http://dx.doi.org/10.7554/eLife.01519.024](10.7554/eLife.01519.024)10.7554/eLife.01519.025Figure 7---figure supplement 1.Circular dichroism spectra showing comparison of *Ec*DTD mutants with the wild type.**DOI:** [http://dx.doi.org/10.7554/eLife.01519.025](10.7554/eLife.01519.025)

Discussion {#s3}
==========

The study provides insights into a fundamental enantioselective mechanism involved in enforcement of homochirality in proteins by specifically decoupling D-aas from tRNAs. The earlier structural studies on DTD provided a mechanistic model based either on docking approaches using apo structure ([@bib25]) or complex structures with ligands that do not mimic the cognate substrate ([@bib3]). A superposition of the earlier known structures with that of the D-Tyr3AA-bound complex presented here shows that the docked substrate as well as the free D-aas and ADP were positioned outside the actual binding pocket ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). Therefore, the key to identifying the mechanism, as seen from this study, is the capturing of the D-Tyr3AA ligand that is bound in the actual substrate-binding pocket.

An analysis of all known structures of proofreading domains in complex with post-transfer substrate analogs helped us to define certain parameters such as percentage buried surface area of the ligand, number of interactions, conservation of interacting residues etc that can be used to assess the binding characteristics of ligand complexes ([Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}, [Supplementary file 1C](#SD1-data){ref-type="supplementary-material"}). Comparison of these parameters from all known complex structures of proofreading domains with the structure presented in the current study places our structure in the same bracket as the other well-studied proofreading domains ([Supplementary file 1C](#SD1-data){ref-type="supplementary-material"}). We have mutated Phe89 that has been shown to stack with adenine in ADP-complex ([@bib3]), to Ala and show that the mutant is as active as the wild-type *Pf*DTD ([Figure 3---figure supplement 2A,C](#fig3s2){ref-type="fig"}). The corresponding mutant F79A in *Ec*DTD was also completely active suggesting that the Phe has no significant role in binding the adenine ([Figure 3---figure supplement 2D](#fig3s2){ref-type="fig"}). Furthermore, the earlier work had implicated a conserved Thr90 as the catalytic residue that was proposed to mount a nucleophilic attack on the carbonyl carbon of the substrate ([@bib25]; [@bib3]). However, our analysis clearly shows that not only the distance (5.72 Å) of γ-hydroxyl group of Thr90 from the carbonyl carbon is unfavorable for any nucleophilic attack but also it is oriented away from the point of attack where it is strongly tethered to Thr152 main chain atoms through a highly conserved cross-subunit interaction ([Figure 3---figure supplement 2B](#fig3s2){ref-type="fig"}). To experimentally demonstrate that Thr90 is not the catalytic residue as had been proposed earlier, we mutated this residue to Ala in both *Pf*DTD and *Ec*DTD, and showed that they still efficiently deacylated D-Tyr-tRNA^Tyr^ ([Figure 3---figure supplement 2C,D](#fig3s2){ref-type="fig"}). These data, therefore, rule out the earlier propositions not only with respect to the adenosine-binding site but also the catalytic mechanism.

More importantly, the current study identifies the key role of an invariant cross-subunit Gly-*cis*Pro motif in solving a fundamental problem of absolute configuration-based selectivity. The most striking feature of the Gly-*cis*Pro motif is the near-parallel fixation of the two carbonyl groups at an angle of ∼20°, a highly conserved structural feature in DTDs irrespective of the presence or absence of ligand as seen in 72 different observations (including 10 from this study) from five different organisms ([Figure 8A](#fig8){ref-type="fig"}). The Ramachandran dihedral angles of both residues remarkably illustrate a striking conservation, which allows DTD to selectively recognize the chiral centre. It also provides a structural explanation for having an invariant Gly in that position as no other residue can normally lie in that region of Ramachandran map ([Figure 8B,C](#fig8){ref-type="fig"}). Since the cellular milieu will be in abundance with L-aa-tRNAs, when compared to D-aa-tRNAs, such a positioning of the critical enantioselective components, as seen here, prevents even a promiscuous deacylation of L-aa-tRNAs leading to their depletion from the pool, as shown by the biochemical studies with 1000-fold excess of DTD in two different systems. The essential role of Gly-*cis*Pro motif in chiral discrimination is also strongly indicated by its absolute invariance in all DTD sequences from eubacteria to higher eukaryotes ([Figure 8C](#fig8){ref-type="fig"}). Previous work has shown the ability of L-proline to catalyze asymmetric synthesis of simple sugars leading to their enantioenrichment ([@bib6]; [@bib18]). Based on the work, there has been a proposal of a role of L-proline in symmetry-breaking during the prebiotic era. In the present work also, we show the critical role of a proline residue as a part of a motif in a process involved in enforcement of homochirality.10.7554/eLife.01519.026Figure 8.Strict conservation of the Gly-*cis*Pro motif in DTDs.(**A**) The structural superimposition of --NXGP(V/F)T-- motif from 72 different monomers of DTD (10 from this study and 62 from PDB including DTDs from *E. coli*, *H. influenzae*, *Plasmodium falciparum*, *Aquifex aeolicus*, and *H. sapiens*) shows that the rigid fixation of Gly149 and Pro150 carbonyl groups is structurally conserved in all DTDs. (**B**) Ramachandran map for residues from --NXGP(V/F)T-- motif from all DTD structures shows that glycine invariably occupies the lower right quadrant. (**C**) Both Gly and Pro are invariant in all DTD sequences.**DOI:** [http://dx.doi.org/10.7554/eLife.01519.026](10.7554/eLife.01519.026)

Overall, the work has unveiled a fundamental cellular mechanism that is responsible for enforcing and perpetuating L-aa homochirality in proteins. A mechanistically unique solution to the problem of enantioselectivity employing two carbonyl oxygens from a 'cross-subunit' Gly-*cis*Pro dipeptide has been shown to be responsible for D-chirality selection and strict L-chirality rejection from the active site of DTD. The conserved and indispensable nature of the motif in DTD argues strongly for its crucial role in solving this key chiral discrimination problem in biology. The presence of DTD-fold and function in all kingdoms of life suggests an important role such systems have played in enforcing homochirality during early evolution of the translational apparatus, and high levels of expression in neuronal cells indicate a crucial role of DTD in higher organisms, which still needs to be explored.

Materials and methods {#s4}
=====================

Cloning, expression and protein purification {#s4-1}
--------------------------------------------

The gene encoding DTD was PCR amplified from *P. falciparum* genomic DNA and inserted between *Nde*I and *Xho*I sites of pET-21b vector (Novagen, Billerica, MA). For untagged construct, a stop codon was incorporated in the reverse primer whereas in case of C-terminal 6X His-tagged (C-His) construct, there was no stop codon in the reverse primer. Untagged protein was used for crystallization and biochemical analysis, while NMR experiments were performed with C-His protein. The recombinant plasmid containing our gene of interest was transformed in *E. coli* BL21 (DE3) cells for overexpression. The untagged protein was purified by a two-step protocol including cation exchange chromatography (CEC) followed by gel filtration chromatography (GFC). In CEC, the induced cell lysate was loaded onto Sulfopropyl-Sepharose column (Amersham Pharmacia, UK) pre-equilibrated with 50 mM BisTris pH 6.5, 20 mM NaCl and then eluted in a linear gradient of NaCl from 20 mM to 500 mM. The eluted protein was further purified to homogeneity by GFC using a Superdex-75 column (Amersham Pharmacia). The final protein was concentrated to 10 mg/ml. *Ec*DTD was purified as mentioned previously ([@bib20]). All proteins were expressed normally except for G137A and double mutant G137A/P138A of *Ec*DTD, which were purified from inclusion bodies using the following procedure. After lysis, the inclusion bodies were washed thoroughly with buffer containing 1% Triton X-100, followed by 1% sodium deoxycholate wash and finally incubated overnight in unfolding buffer containing 6M guanidinium hydrochloride (GdmHCl). The unfolded protein was then loaded onto Ni-NTA column (Amersham Pharmacia) pre-equilibrated with unfolding buffer and subsequently washed with 1% Triton X-100, followed by 0.1% β-cyclodextrin wash. This was followed by 30 mM imidazole wash to get rid of any contaminant proteins. The protein was finally eluted with 250 mM imidazole and immediately diluted in refolding buffer containing 400 mM L-Arg. The protein was further purified to homogeneity using GFC. Circular Dichroism analysis was performed to ensure that the proteins were properly folded ([Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}).

Co-crystallization with substrate-mimicking analog D-Tyr3AA {#s4-2}
-----------------------------------------------------------

Co-crystallization was attempted with a number of constructs of DTD from *E. coli*, *Mycobacterium tuberculosis*, *Vibrio cholera*, *Leishmania major* but none of them yielded a ligand-bound structure. Successful co-crystallization was achieved only with *Pf*DTD. The nonhydrolyzable analogs D-Tyr3AA, L-Tyr3AA, and D-Tyr2AA were obtained after custom synthesis from Jena Biosciences, Germany. The pure protein sample was mixed with the ligand in a molar ratio of 1:20 and the premix was incubated at 4°C overnight. Initial crystallization conditions were screened at 4°C and 20°C with Index and Crystal screen 1 and 2 (Hampton Research, Aliso Viejo, CA) and JBS classic (Jena Biosciences) in sitting drop setups using 96-well plates from MRC. The experiments were set up by mixing 1 μl of protein:ligand premix with 1 μl of reservoir buffer with the help of Mosquito crystallization robot (TTP LabTech, UK). The hits obtained were further optimized in a hanging drop vapor diffusion setup using 24-well Iwaki plates. *Pf*DTD+D-Tyr3AA crystal I was obtained in 0.1M HEPES pH 7.0, 0.6M NaCl, 32% PEG3350, while crystal II of the same was obtained in 0.1M BisTris pH 6.0, 0.4 M NaCl, 28% PEG3350.

X-ray diffraction data collection and structure determination {#s4-3}
-------------------------------------------------------------

The diffraction data were collected at the in-house X-ray facility after screening several hundreds of ligand complex crystals to get high resolution datasets. The dataset for *Pf*DTD+D-Tyr3AA crystal I was collected using RigakuMicromax007 HF rotating-anode generator that produces CuKα X-rays of wavelength 1.54 Å and MAR345dtb image-plate detector from MAR Research. The crystal was mounted on a nylon loop and flash-cooled directly without the use of any cryoprotectant solution in a nitrogen-gas stream at 100 K using Oxford Cryostreamcooler (Oxford Cryosystems, UK). The dataset for *Pf*DTD+D-Tyr3AA crystal II was collected using FR-E+ SuperBright X-ray generator from Rigaku equipped with VariMax HF optic and R-AXIS IV++ image plate detector. The data were processed using HKL2000 ([@bib32]) and the structure was solved by molecular replacement using MOLREP-AUTO MR from the CCP4 suite ([@bib10]) with *Pf*DTD apo structure (PDB id: [3KNF](http://www.rcsb.org/pdb/explore/explore.do?structureId=3KNF)) as the search model. The structure was refined with the help of CNS ([@bib7]) and REFMAC ([@bib29]), while COOT ([@bib13]) was used for model building. The restraints for refinement of ligand molecules were obtained from PRODRG server ([@bib36]). The structure was validated using PROCHECK ([@bib23]) and the figures were generated with the help of PyMOL ([@bib35]).

Biochemical assays {#s4-4}
------------------

The mutants for biochemical assays were generated using QuickChange XL site-directed kit (Stratagene, La Jolla, CA) and the proteins were purified by the same protocol as for the wild type. *E. coli* tRNA^Tyr^ was transcribed in vitro using MEGAshortscript (Ambion, Austin, TX) and 3' end-labeled using standard protocol by incubating the tRNA with CCA-adding enzyme in presence of \[α-^32^P\]-ATP ([@bib24]). D-Tyr-tRNA^Tyr^ and L-Tyr-tRNA^Tyr^ were generated by incubating 20 mM Tris pH 7.8, 7 mM MgCl~2~, 5 mM Dithiothreitol (DTT), 2 mM ATP, 0.2 mM amino acid (D-Tyr or L-Tyr), 0.5 μM labeled tRNA^Tyr^, 1 U/ml pyrophosphatase with 2 μM purified *E. coli* TyrRS at 37°C for 15 min. Aminoacylation reaction was followed by phenol extraction and ethanol precipitation of aminoacylated tRNA, which was finally resuspended in 5 mM sodium acetate pH 4.6. Deacylation assays were performed by incubating 20 mM Tris pH 7.2, 5 mM MgCl~2~, 5 mM DTT, 0.2 mg/ml bovine serum albumin (BSA), 0.2 μM labeled D-Tyr-tRNA^Tyr^ or L-Tyr-tRNA^Tyr^ at 30°C with 500 pM of *Pf*DTD and 50 nM of *Ec*DTD or the mutants enzyme as the case may be. Reaction mix at various time points were subjected to S1 nuclease digestion for 30 min at 22°C and analyzed by thin-layer chromatography (TLC) by spotting 1 μl on PEI cellulose sheet (Merck KGaA, Germany). An example of a TLC run has been shown in [Figure 5---figure supplement 3](#fig5s3){ref-type="fig"}. The mobile phase for TLC was composed of 100 mM ammonium chloride and 5% glacial acetic acid. TLC sheets were exposed to imaging plate from Fujifilm, Japan. Phosphor imaging was done using Typhoon Trio Variable Mode Imager (Amersham Biosciences, Piscataway, NJ) and Image Gauge V4.0 software was used for quantification. Each experiment was carried out in triplicates.

Transverse relaxation optimized NMR spectroscopy {#s4-5}
------------------------------------------------

2D ^15^N-^1^H TROSY experiments were performed on a Bruker 600 MHz NMR spectrometer equipped with triple resonance cryoprobe (Bruker, Billerica, MA). C-His construct of *Pf*DTD was expressed in minimal media with ^15^NH~4~Cl as the sole nitrogen source in order to achieve uniform labeling. The protein was purified by affinity chromatography using Ni-NTA column in batch mode. For binding studies, 200 μM U-^15^N-*Pf*DTD in 50 mM HEPES pH 7.0, 50 mM NaCl was titrated with substrate analogs. Chemical shift perturbations in *Pf*DTD upon titration were monitored by a series of 2D ^15^N-^1^H TROSY spectra collected with increasing concentrations of ligand. Four datasets were recorded for each ligand at protein:ligand molar ratios of 1:0, 1:5, 1:10, and 1:15. The experiments were repeated twice with two different batches of protein. The data processing and figure preparation were done using Sparky.
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\(A\) Interaction distances (Å) of the aminoacyl moiety of D-Tyr3AA with active site residues; (B) Atomic B-factors (Å^2^) of D-Tyr3AA atoms in all monomers from crystal forms I and II; (C) Various aspects of post-transfer substrate analog-bound structures of proofreading domains from earlier work and the current study along with ADP-bound structure of PfDTD ([@bib3]) and docked substrate model ([@bib25]).
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Major datasets
--------------

The following datasets were generated:

AhmadS, RouthSB, KamarthapuV, SankaranarayananR, 2013,D-aminoacyl-tRNA deacylase (DTD) from *Plasmodium falciparum* in complex with D-tyrosyl-3'-aminoadenosine at 1.86 Angstrom resolution,<http://www.rcsb.org/pdb/explore/explore.do?structureId=4NBI>,Publicly available at RCSB Protein Data Bank ([http://www.rcsb.org](http://www.rcsb.org/)).

AhmadS, RouthSB, KamarthapuV, SankaranarayananR, 2013,D-aminoacyl-tRNA deacylase (DTD) from *Plasmodium falciparum* in complex with D-tyrosyl-3'-aminoadenosine at 2.20 Angstrom resolution,<http://www.rcsb.org/pdb/explore/explore.do?structureId=4NBJ>,Publicly available at RCSB Protein Data Bank ([http://www.rcsb.org](http://www.rcsb.org/)).
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eLife posts the editorial decision letter and author response on a selection of the published articles (subject to the approval of the authors). An edited version of the letter sent to the authors after peer review is shown, indicating the substantive concerns or comments; minor concerns are not usually shown. Reviewers have the opportunity to discuss the decision before the letter is sent (see [review process](http://elife.elifesciences.org/review-process)). Similarly, the author response typically shows only responses to the major concerns raised by the reviewers.

\[Editors' note: the authors performed additional work to address the concerns raised in the first round of peer review and submitted for further consideration. The two decision letters after peer review are shown below.\]

Thank you for choosing to send your work entitled "Mechanism of chiral proofreading during translation of the genetic code" for consideration at *eLife*. Your full submission has been evaluated by a Senior editor and 2 peer reviewers, and the decision was reached after discussions between the reviewers. We regret to inform you that your work will not be considered further for publication.

In this paper, the X-ray crystal structure of *Plasmodium falciparum* D-aminoacyl-tRNA deacylase (DTD) in a liganded complex with a non-hydrolysable D-tyrosine analogue, D-tyrosyl-3\'-aminoadenosine, is presented. The reviewers recognize that the work is a significant contribution to the field and provides further insight into the catalytic mechanism of this enzyme, the details of which could not be determined from the previously solved apo-structure. The authors use mutagenic studies to demonstrate the crucial catalytic role of the highly conserved Gly-*cis*Pro motif within the enzyme as well as showing structurally the importance of this motif in chiral selection. In addition the findings also indicate that this particular DTD is likely to only act upon aminoacylated-tRNA species when the amino acid is attached to the 3\' hydroxyl of the terminal adenine of the tRNA donor molecule. Nevertheless, the review has raised some major concerns that have led to the conclusion that the paper is not suitable for publication by *eLife*.

1\) The major issues arise from placing the present work in the context of what is already known about the enzyme. The crystal structure of DTD has been determined earlier. A model docking the substrate analogs with DTD from different sources have also been obtained. Crystal structures of PfDTD with adenosine and different D amino acids have led to a mechanical model that is contrary to the model suggested here. Conclusions in the present manuscript go too far beyond what the data indicate.

The details of the reaction mechanism are still not completely defined, and so one has to make the hypothesis that the observed binding mode is the relevant one. The statement 'Previous attempts using several apo and complex structures \... yielded the first cognate ligand-bound structure and provided the structural basis of this fundamental cellular process' is misleading. It has been shown that D-Tyr-adenosine was not hydrolyzed by DTD, but a D-Tyr-esterified oligonucleotide produced by RNase T1 digestion of D-Tyr-tRNA having a 19mer oligonucleotide, is its substrate ([@bib16]). Therefore, present ligand is also a model system for interpretation of the possible mode of substrate binding and catalytic action.

2\) In addition to Gly*cis*Pro, there are several other amino acids involved in the interactions with the ligand ([Figure 1](#fig1){ref-type="fig"}) and if the true substrate that is much larger were to be bound, there would have been many contacts. The authors spent a lot of effort in highlighting the conserved nature of these two residues and their stereochemistry. How does one rule out other possible conserved interactions even if there are sequence differences in the binding pocket?

3\) The binding pocket conformation has been assumed to be very rigid while attempting to illustrate that L-amino acid analogs would be sterically excluded ([Figure 2](#fig2){ref-type="fig"}). This has been substantially based on the conserved nature of the Gly*cis*Pro motif ([Figure 6](#fig6){ref-type="fig"}). In principle, the substrate binding pocket of an enzyme has to have certain amount of plasticity and even if the stereochemistry of a couple of residues is conserved, possible structural changes due to the plasticity associated with other residues can not be ruled out. Indeed, this argument is consistent with the degenerate recognition of diverse D-amino acids in case of the same enzyme ([@bib3]). This is important particularly considering that the true substrate is much bigger than the ligand used here. While it is accepted that the L-amino acids are rejected, one has to be cautious about interpreting the mechanism based on the rigidity of a motif consisting of only two amino acids from the binding pocket.

4\) [@bib3] have provided 'atomic snap shots' for the catalytic mechanism of DTD based on the crystal structures of several complexes of DTD with many D-amino acids and ADP binding. The model proposed in their case emphasizes substantial plasticity at the binding site and highlights the possible catalytic steps. The authors of the present study reject that model based on two counts: they were not cognate ligand complexes and their binding modes are different. Knowing that D-Tyr-adenosine is also not a true substrate of DTD, better explanation would be required to rule out the earlier described binding modes considering they also involve D-amino acids and adenosine.

\[Editors' note: what now follows is the decision letter after additional work had been performed.\]

Thank you for submitting your work entitled "Mechanism of chiral proofreading during translation of the genetic code" for further consideration at *eLife*. Your revised article has been favorably evaluated by a Senior editor and the original two reviewers. The manuscript has been improved but there are some remaining issues that need to be addressed before acceptance, as outlined below:

In this paper, the X-ray crystal structure of *Plasmodium falciparum* D-aminoacyl-tRNA deacylase (DTD) in a liganded complex with a non-hydrolysable D-tyrosine analogue, D-tyrosyl-3\'-aminoadenosine, is presented. The work is a significant contribution to the field and provides further insight into the catalytic mechanism of this enzyme, the details of which could not be determined from the previously solved apo-structure. The authors use mutagenic studies to demonstrate the crucial catalytic role of the highly conserved Gly-*cis*Pro motif within the enzyme as well as showing structurally the importance of this motif in chiral selection. In addition the findings also indicate that this particular DTD is likely to only act upon aminoacylated-tRNA species when the amino acid is attached to the 3\' hydroxyl of the terminal adenine of the tRNA donor molecule.

An earlier version of this manuscript had been rejected previously, but the authors have done a good job of responding to the criticisms of the previous version by providing additional data concerning the validity of the binding mode of the substrate analog, and by making changes to the text of the manuscript.

The authors should revise the manuscript taking into account the following points. The paper will not be sent out for review again and the editor will make a final decision based the revisions made to the manuscript. Please respond to all of these points by revising the manuscript appropriately.

1\) The authors now describe mutations that indicate that the binding mode they see is relevant to catalysis. They also carry out some mutations around the active site that support nucleotide-mediated catalysis, although this point in not rigorously proven because the data are negative (i.e., mutations do not affect catalysis substantially). Hence, they should be careful to tone down the discussion regarding previously solved structures of DTD with other ligands. The focus should be on what can be definitively concluded from the combination of structures presented here and other earlier structures rather than just over stating apparent 'failures' of either. This would allow for better discussion of the different catalytic mechanisms proposed from earlier structures obtained with other ligands and what is proposed to be the case here. Specifically, the Introduction should describe the earlier structural work and place the present work properly in context of the previous work, before moving on to a discussion of the present work.

2\) It is very difficult to place the results discussed here in the context of DTD from various species (eukaryotes, prokaryotes, mammals\...). The Abstract should state which species is analyzed, and the Introduction should also state more clearly the extent to which DTD is conserved in different species and which ones are analyzed here. It is true that this information is available in the manuscript, but it should be provided up front and in a way that the reader can immediately appreciate.

3\) The word "novel" should be deleted from the Abstract. It is not clear in what sense the solution that this enzyme has reached for specificity is "novel" and in any case the novelty should be left for others to judge.

4\) In the discussion of the active site mutants, it is stated "The above data clearly demonstrate that none of the protein residues around the scissile bond are involved in catalysis." Since only negative data are presented, this statement is too strong. Change "clearly demonstrate" to "indicate" or some other appropriate word. Likewise, a little later the paper states "...the above data strongly suggest that the DTD fold is designed to be an RNA-based catalyst in the proofreading reaction". Again, in the absence of positive data about the mechanism, replace "strongly suggest" by "are consistent with" or some other appropriate wording.

5\) Towards the end of the paper it is said "These data, therefore, clearly show the lack of functional relevance of the binding modes proposed earlier\...". This is too strong. How do the authors know that the previously seen binding modes are not intermediates for some part of the process of catalysis? Remove this wording and replace with appropriate text.

6\) A little later, it is stated "More importantly, the current study identifies and reveals for the first time the key role of an invariant cross-subunit Gly-*cis*Pro motif in solving\....". Delete "and reveals for the first time". This work is built on earlier structural work and it is sufficient to say that it identifies a key role for this motif.

7\) The paragraph in the Discussion beginning "The study opens up important questions\...." should be deleted. It is too speculative, and it is far from certain that the structure can be used to design DTD enzymes to create a "D-amino acid world".

10.7554/eLife.01519.029

Author response

*1) The details of the reaction mechanism are still not completely defined, and so one has to make the hypothesis that the observed binding mode is the relevant one. The statement 'Previous attempts using several apo and complex structures \... yielded the first cognate ligand-bound structure and provided the structural basis of this fundamental cellular process' is misleading. It has been shown that D-Tyr-adenosine was not hydrolyzed by DTD, but a D-Tyr-esterified oligonucleotide produced by RNase T1 digestion of D-Tyr-tRNA having a 19mer oligonucleotide, is its substrate (*[@bib16]*). Therefore, present ligand is also a model system for interpretation of the possible mode of substrate binding and catalytic action*.

We totally agree with the reviewers that the ligand used in the study is also not the real substrate for DTD. However, such post transfer analogs where the amino acid is linked to the adenosine moiety through non-hydrolyzable amide linkage has been extensively used in crystallographic studies to elucidate proofreading mechanisms in atomic details. We have now provided in the main text all the references where these analogs were used to decipher the structural basis of proofreading mechanism both in class I and class II aminoacyl-tRNA synthetases, which were further validated biochemically. In our current manuscript, we have added additional data to experimentally demonstrate that the ligand-bound complex we have obtained is the functionally relevant one by disrupting the adenine pocket with the help of mutations and showing that it leads to complete loss of activity in two different systems, i.e., *Pf*DTD and *Ec*DTD ([Figure 3--figure supplement 1](#fig3s1){ref-type="fig"}). As can be seen, both these mutations were selected to have opposing structural consequence, one protrudes in the adenine binding pocket and the other removes the naturally occurring stacking interaction. These data clearly show that the adenine binding mode identified in our study is used for the biological function of DTD. In addition, as elaborated later, the mutation of the adenine binding site as predicted by Bhatt et al. did not alter the activity, again done in both *Pf*DTD and *Ec*DTD, clearly showing that it is not the functional adenosine pocket. However, as correctly pointed out by the reviewers, we have modified the text to avoid misleading statements. We have now explicitly referred to our ligand as 'substrate-mimicking analog' instead of 'cognate ligand'.

Further, we have now addressed the mechanism of DTD in a more complete way and propose an RNA-assisted catalytic mechanism involving the role of 2\'-OH. Our additional mutational data including 7 mutants in *Pf*DTD and 4 mutants in *Ec*DTD, where we mutated every residue in the vicinity of the scissile bond, clearly demonstrate that none of the protein side chains play any role in catalysis ([Figure 3--figure supplement 1](#fig3s1){ref-type="fig"}). Moreover, the role of 2\'-OH in catalysis has also been suggested in the case of Pab-NTD, which shares a striking structural similarity with DTD. Although, the catalytic role of vicinal hydroxyl group of ribose in proofreading has been experimentally shown in case of Phenylalanyl-tRNA synthetase (PheRS) by using deoxy analogs (Ling et al., 2010, PNAS (104), 72-77), doing the same for DTD or Pab-NTD has some practical limitations. In the case of Threonyl-tRNA synthetase (ThrRS), 2\'-OH has been shown to play a critical role in aminoacylation reaction also, which means that tRNA^Thr^ with a terminal 2\'-deoxyadenosine (2\'-dA) cannot be charged. In the case of Tyrosyl-tRNA synthetase (TyrRS), the problem is even worse since it charges the amino acid on the 2\'-OH of tRNA which then gets transesterified to 3\'-OH. Therefore, generating substrate for DTD with tRNA^Tyr^-2\'-dA would not be possible. These practical limitations make it difficult to directly verify the catalytic role of 2\'-OH in both DTD and Pab-NTD. However, the lack of involvement of any protein residues in catalysis strongly suggests a role of RNA in catalysis, as shown in the case of PheRS. The above aspect on catalysis with the new mutational data has been extensively dealt with in the new manuscript, while the overall focus is still on the unique chiral discrimination mechanism of DTD.

As we understand, one of the major concerns of the reviewers earlier was about the 'authenticity' of the ligand-binding mode as observed in our complex structure. Earlier we have presented mutational data on the Gly-*cis*Pro that abolished the biochemical activity of DTD. Now, we present direct experimental evidence, as correctly prompted by the reviewers, on the indispensible role of adenosine binding pocket as well. Therefore, independent mutational data on two discrete sites separated by ∼12 Å, as identified by D-Tyr3AA-bound complex, showing an essential role in activity clearly demonstrate that the binding mode observed is the functionally relevant one.

*2) In addition to Gly*cis*Pro, there are several other amino acids involved in the interactions with the ligand (*[*Figure 1*](#fig1){ref-type="fig"}*) and if the true substrate that is much larger were to be bound, there would have been many contacts. The authors spent a lot of effort in highlighting the conserved nature of these two residues and their stereochemistry. How does one rule out other possible conserved interactions even if there are sequence differences in the binding pocket*?

We absolutely agree with the reviewers that there are conserved critical interactions of the ligand with residues other than Gly-*cis*Pro such as invariant Phe137 and highly conserved Ser87, Gln88, and Gly138. We probably downplayed these interactions inadvertently because of our overemphasis on Gly-*cis*Pro motif and its critical role in enantioselection. We have now made suitable modifications in the manuscript to discuss more about the other conserved interactions of the ligand in DTD. We have added another section in the Results to bring out the essence of these interactions more. In addition, we have compared these interactions in DTD with that in Pab-NTD to highlight the conservation of adenine recognition in this fold ([Figure 2--figure supplement 4](#fig2s4){ref-type="fig"}). We have also provided more mutational data to support the critical role of these interactions in ligand binding ([Figure 3](#fig3){ref-type="fig"}).

*3) The binding pocket conformation has been assumed to be very rigid while attempting to illustrate that L-amino acid analogs would be sterically excluded (*[*Figure 2*](#fig2){ref-type="fig"}*). This has been substantially based on the conserved nature of the Gly* cis*Pro motif (*[*Figure 6*](#fig6){ref-type="fig"}*). In principle, the substrate binding pocket of an enzyme has to have certain amount of plasticity and even if the stereochemistry of a couple of residues is conserved, possible structural changes due to the plasticity associated with other residues can not be ruled out. Indeed, this argument is consistent with the degenerate recognition of diverse D-amino acids in case of the same enzyme (*[@bib3]*). This is important particularly considering that the true substrate is much bigger than the ligand used here. While it is accepted that the L-amino acids are rejected, one has to be cautious about interpreting the mechanism based on the rigidity of a motif consisting of only two amino acids from the binding pocket*.

We thank the reviewers for pointing out this very important aspect that we again feel is an impression resulting from our overemphasis on Gly-*cis*Pro motif and its conserved stereochemistry. In reality, the active site of DTD has substantial plasticity as highlighted by the subtle rearrangements of the active site residues upon ligand binding. We have now included a figure that compares the active site residues in the apo form and the ligand-bound form to illustrate this plasticity associated with the active site ([Figure 2D](#fig2){ref-type="fig"}). However, we respectfully disagree that the 'degenerate recognition of diverse D-amino acids', as observed by Bhatt et al., in any way indicates the plasticity of active site. We have dealt with the problems associated with these structures in detail in concern 4.

*4)* [@bib3] *have provided 'atomic snap shots' for the catalytic mechanism of DTD based on the crystal structures of several complexes of DTD with many D-amino acids and ADP binding. The model proposed in their case emphasizes substantial plasticity at the binding site and highlights the possible catalytic steps. The authors of the present study reject that model based on two counts: they were not cognate ligand complexes and their binding modes are different. Knowing that D-Tyr-adenosine is also not a true substrate of DTD, better explanation would be required to rule out the earlier described binding modes considering they also involve D-amino acids and adenosine*.

We now provide confirmatory experimental evidence to not only rule out the earlier ligand binding modes but also the proposed catalytic mechanism. We have also included an analysis that compares the earlier binding modes with our complex structure in the light of all known post transfer substrate analog-bound structures of proofreading domains ([Figure 1--figure supplement 2](#fig1s2){ref-type="fig"}). Our analysis highlights features of the earlier binding modes that are totally uncharacteristic of biologically relevant complex. We deal with the ADP and D-amino acid complexes separately below:

ADP complex:

First of all, ADP is neither a substrate for DTD nor for any other proofreading domain. Even if we consider it as a mimic of the substrate since it also has an adenosine moiety, there are serious issues with the mode of binding observed in the ADP-bound structure. Going by the general principles of enzyme-substrate interactions, the ligand in a biologically relevant complex is expected to bind in the deepest available pocket with strong surface complementarity and chemical compatibility with a conserved network of interactions. As we now show in [Figure 1--figure supplement 2](#fig1s2){ref-type="fig"}, where we compare the ADP-bound structure with our structure and all the known complexes of proofreading domains, the ADP binds in a site that leaves the deepest pocket unoccupied unlike our structure or any other known complex structure of proofreading domains. Moreover, the striking surface complementarity that is evident in all complex structures including ours is totally absent in ADP complex. Secondly, the binding of ADP buries less than 50% of the ligand that is much less than the values that are mostly in the range of 80% for all known complex structures including ours. Thirdly, the biologically relevant complexes exhibit a remarkable redundancy of observation wherein the presence of ligand is observed in every monomer. Although such a redundancy is seen in our structure, where the ligand D-Tyr3AA has been observed in all ten monomers from 2 different crystal forms, ADP has only been sporadically observed in just 7 out of 18 monomers. Lastly and most importantly, a biologically relevant complex is expected to have a substantial number of interactions between the ligand, and the enzyme and the residues involved in these interactions must be evolutionarily conserved. Such evolutionarily conserved interactions are observed in all proofreading domain complexes as well as our structure but are missing in ADP complex.

In order to experimentally prove that the ADP complex has no biological relevance we have mutated Phe89 (which is the only conserved residue that interacts with ADP by stacking with the adenine ring) to Ala in both *Pf*DTD and *Ec*DTD, and show that the mutant is still completely active. To this effect we have added [Figure 3--figure supplement 2](#fig3s2){ref-type="fig"} in the manuscript. These data, therefore, clearly rule out any functional significance of the ADP complex.

D-amino acid complexes:

Just as in case of ADP, free D-amino acids are also not the substrate for DTD rather they are the products of the reaction. Even if we assume them to partly mimic the actual substrate, the D-amino acid complexes reported have some serious problems as discussed below. First of all, these structures (except D-Lysine complex) have been solved at resolutions ranging from 2.75 Å to 3.00 Å, which makes the accurate modeling of free D-amino acids difficult. It may be noted that in most of these structures even waters have not been modeled. Secondly, in most cases the D-amino acid has only been modeled in just 1 out of 6 monomers highlighting a lack of redundancy of observations. Thirdly, the D-amino acids have been modeled with minimal interactions with the protein (in some cases there is no interaction between D-amino acid and protein at all). Even these minimal interactions with protein residues are not evolutionarily conserved at all. All these features are highly unexpected of a functionally relevant complex. Moreover, as we have illustrated in [Figure 1--figure supplement 1](#fig1s1){ref-type="fig"}, the position as well as orientation of all D-amino acids is highly variable. In some cases the carboxylate group points towards the enzyme, whereas in some cases it points outwards. This variable mode of D-amino acid binding has been possibly misconstrued as plasticity of active site and has been used to explain DTD's activity against multiple D-amino acids ([@bib3]). We do not think that the above argument holds good given the fact that the actual substrate for DTD is D-aminoacyl-tRNA, which means that D-amino acid would be ester linked to the terminal adenosine of tRNA. Therefore, the position as well as the orientation of D-amino acid in a functional complex would be fixed by the adenosine-binding pocket. In order to accommodate all the modes of D-amino acid binding observed, DTD must have multiple adenosine binding pockets as well, which is a highly improbable scenario. In any case, the observed modes of D-amino acid complexes do not provide any explanation for the chiral selection mechanism. On the other hand, the side chain-independent mode of D-Tyr3AA binding that we observe in the current study not only elucidates this chiral discrimination mechanism but also elegantly explains the ability of DTD to act on multiple D-amino acids, even when they are bound in a fixed orientation.

Based on their 'atomic snapshots', [@bib3] had proposed a catalytic mechanism implicating the role of Thr90 in mounting a nucleophilic attack on the carbonyl carbon of the substrate. However, our structure clearly shows that the distance and orientation of the γ-hydroxyl group of Thr90 is unfavorable for the proposed nucleophilic attack ([Figure 3--figure supplement 2B](#fig3s2){ref-type="fig"}). In order to experimentally rule out the earlier proposed catalytic mechanism, we have now mutated Thr90 to Ala in both *Pf*DTD and *Ec*DTD and show that the mutants are completely active ([Figure 3--figure supplement 2C, D](#fig3s2){ref-type="fig"}).

With these additional analyses and data, we unequivocally rule out the earlier structural model both statistically and experimentally not only in terms of ligand binding mode but also in terms of the proposed catalytic mechanism. It is for the reasons above that the earlier studies could not identify the functionally critical residues and hence were unable to provide the structural basis for the chiral proofreading mechanism.

\[Editors' note: the author responses to the second round of peer review follow.\]

*1) The authors now describe mutations that indicate that the binding mode they see is relevant to catalysis. They also carry out some mutations around the active site that support nucleotide-mediated catalysis, although this point in not rigorously proven because the data are negative (i.e., mutations do not affect catalysis substantially). Hence, they should be careful to tone down the discussion regarding previously solved structures of DTD with other ligands. The focus should be on what can be definitively concluded from the combination of structures presented here and other earlier structures rather than just over stating apparent 'failures' of either. This would allow for better discussion of the different catalytic mechanisms proposed from earlier structures obtained with other ligands and what is proposed to be the case here. Specifically, the Introduction should describe the earlier structural work and place the present work properly in context of the previous work, before moving on to a discussion of the present work*.

We agree with the reviewers that the discussions should be toned down on the apparent failure of the earlier work. Our original manuscript was along that line but to address certain criticisms during the review process we had incorporated those changes. However, we have now removed those parts as suggested. We have now modified the last paragraph in the Introduction section to describe all the previous structural work carried out on DTD and the information that was already available before the current study. We have also mentioned the proposals that were based on these structural studies in the same paragraph and then highlighted the findings of the current work, which the earlier reports did not provide, in the Discussion section. We have now condensed the first three paragraphs of the Discussion section to two in order to completely tone down the criticism of the earlier work. We have also removed the Table S4 from the supplementary material which was redundant in referring to the lacunae in the earlier work.

*2) It is very difficult to place the results discussed here in the context of DTD from various species (eukaryotes, prokaryotes, mammals\...). The Abstract should state which species is analyzed, and the Introduction should also state more clearly the extent to which DTD is conserved in different species and which ones are analyzed here. It is true that this information is available in the manuscript, but it should be provided up front and in a way that the reader can immediately appreciate*.

In response to this concern, we have now incorporated the name of the species analyzed in the third sentence of the Abstract. We have also modified the Introduction section to comprehensively describe the distribution of DTD in the biological world. In the same paragraph, we have also added a statement on conservation of DTD sequence between *E. coli* and humans to indicate the extent of conservation of this enzyme. Moreover, we clearly state the species used for various analyses in the last paragraph of the Introduction section.

*3) The word "novel" should be deleted from the Abstract. It is not clear in what sense the solution that this enzyme has reached for specificity is "novel" and in any case the novelty should be left for others to judge*.

We have removed the word "novel" from the Abstract.

*4) In the Discussion of the active site mutants, it is stated "The above data clearly demonstrate that none of the protein residues around the scissile bond are involved in catalysis". Since only negative data are presented, this statement is too strong. Change "clearly demonstrate" to "indicate" or some other appropriate word. Likewise, a little later the paper states "...the above data strongly suggest that the DTD fold is designed to be an RNA-based catalyst in the proofreading reaction". Again, in the absence of positive data about the mechanism, replace "strongly suggest" by "are consistent with" or some other appropriate wording*.

We have changed "clearly demonstrate" to "suggest" as suggested by the reviewers. We have also changed "strongly suggest" to "indicate" as suggested.

*5) Towards the end of the paper it is said "These data, therefore, clearly show the lack of functional relevance of the binding modes proposed earlier\...". This is too strong. How do the authors know that the previously seen binding modes are not intermediates for some part of the process of catalysis? Remove this wording and replace with appropriate text*.

We have toned down the statement "These data, therefore, clearly show the lack of functional relevance of the binding modes proposed earlier\..." by changing it to "These data, therefore, rule out the earlier propositions..."

*6) A little later, it is stated "More importantly, the current study identifies and reveals for the first time the key role of an invariant cross-subunit Gly-*cis*Pro motif in solving\...". Delete "and reveals for the first time". This work is built on earlier structural work and it is sufficient to say that it identifies a key role for this motif*.

We have deleted "and reveals for the first time" as suggested by the reviewers.

*7) The paragraph in the Discussion beginning "The study opens up important questions\..." should be deleted. It is too speculative and it is far from certain that the structure can be used to design DTD enzymes to create a "D-amino acid world"*.

We have deleted the concerned paragraph in the Discussion section and added a small part (which we felt was necessary to mention) in the last line of the Discussion.

[^1]: These authors contributed equally to this work.

[^2]: Values in parentheses are for the highest resolution shell.

[^3]: Throughout the refinement, 5% of the total reflections were held aside for R~free~.
